{"id":"https://openalex.org/W295287124","doi":"https://doi.org/10.21236/ada406173","title":"Prostate-Specific Gene Therapy Using a Gutless\" Adeno-Vector Expressing Antisense TGF-Beta and PSA Promoter-Controlled TNF-Alpha Gene\"","display_name":"Prostate-Specific Gene Therapy Using a Gutless\" Adeno-Vector Expressing Antisense TGF-Beta and PSA Promoter-Controlled TNF-Alpha Gene\"","publication_year":2002,"publication_date":"2002-03-01","ids":{"openalex":"https://openalex.org/W295287124","doi":"https://doi.org/10.21236/ada406173","mag":"295287124"},"language":"en","primary_location":{"id":"doi:10.21236/ada406173","doi":"https://doi.org/10.21236/ada406173","is_oa":false,"landing_page_url":"http://doi.org/10.21236/ada406173","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"US Dept of the Army","raw_type":"report"},"volume":null,"type":"report","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108509552","display_name":"Arie S. Belldegrun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Arie S. Belldegrun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5108509552"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psa-promoter","display_name":"PSA promoter","score":0.5979999899864197},{"id":"https://openalex.org/keywords/apo2l-trail","display_name":"Apo2L/TRAIL","score":0.9399999976158142},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.718999981880188},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.8989999890327454},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.8450000286102295},{"id":"https://openalex.org/keywords/targeted-cytotoxicity","display_name":"targeted cytotoxicity","score":0.8479999899864197},{"id":"https://openalex.org/keywords/gfp-reporter","display_name":"GFP reporter","score":0.33799999952316284}],"concepts":[{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.6131035685539246},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.5811589360237122},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.5646893382072449},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.5543441772460938},{"id":"https://openalex.org/C92087593","wikidata":"https://www.wikidata.org/wiki/Q427389","display_name":"Vector (molecular biology)","level":4,"score":0.517732560634613},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4744240641593933},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.472557008266449},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.37747615575790405},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2466660737991333},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.23672932386398315},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12716099619865417},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.06637173891067505},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.05707436800003052},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.21236/ada406173","doi":"https://doi.org/10.21236/ada406173","is_oa":false,"landing_page_url":"http://doi.org/10.21236/ada406173","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"US Dept of the Army","raw_type":"report"},{"id":"pmh:ADA406173","doi":null,"is_oa":false,"landing_page_url":"http://oai.dtic.mil/oai/oai?&verb=getRecord&metadataPrefix=html&identifier=ADA406173","pdf_url":null,"source":{"id":"https://openalex.org/S4406923043","display_name":"Defense Technical Information Center (DTIC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"DTIC AND NTIS","raw_type":"Text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8600000143051147}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W283644099","https://openalex.org/W325371854","https://openalex.org/W2130691538","https://openalex.org/W2030622610","https://openalex.org/W2416968969","https://openalex.org/W1996581677","https://openalex.org/W1551319547","https://openalex.org/W2317667447","https://openalex.org/W2026454120","https://openalex.org/W4256066390"],"abstract_inverted_index":{"The":[0],"goal":[1],"of":[2,19,30,44,91,126,168],"this":[3],"research":[4],"has":[5,123],"been":[6,58],"to":[7,24,118,161],"develop":[8],"an":[9,92],"immune-based":[10],"gene":[11,87,101,170],"therapy":[12,171],"that":[13,67],"combines":[14],"targeted":[15],"cytotoxicity":[16,143],"with":[17,63,135,174],"reversal":[18],"local":[20,31],"tumor":[21,32],"immune":[22,33],"suppression":[23,34],"eradicate":[25],"prostate":[26,48,94,149,178],"cancer":[27,49,150,179],"cells.":[28],"Reversal":[29],"was":[35],"achieved":[36],"in":[37,104,105,144,155,172],"vitro":[38],"by":[39,47],"blocking":[40],"the":[41,85,89,163],"over":[42],"expression":[43,66],"TGF-beta2":[45,52,175],"produced":[46],"cells":[50],"using":[51],"phosphorothinate":[53],"oligonucleotide":[54],"antisense.":[55],"We":[56],"have":[57,71,140],"developing":[59],"a":[60,98,131],"gutless":[61,80],"adenovector":[62,81],"extended":[64],"transgene":[65],"we":[68,139],"think":[69],"will":[70],"enhanced":[72],"safety":[73,167],"for":[74,102,177],"pre-clinical":[75],"and":[76,97,122,166],"clinical":[77],"use.":[78],"Our":[79,108],"DNA":[82],"backbone":[83],"contains":[84],"cytotoxic":[86],"under":[88],"control":[90],"improved":[93,109],"specific":[95],"promoter":[96],"marker":[99],"GFP":[100],"detection":[103],"vivo":[106,156],"studies.":[107],"PSA":[110,120],"promoter/enhancer":[111,121],"presents":[112],"19-fold":[113],"higher":[114],"transcriptional":[115],"activity":[116],"compared":[117],"native":[119],"no":[124],"loss":[125],"tissue":[127],"specificity.":[128],"Using":[129],"Apo2L/TRAlL,":[130],"TNF-a":[132],"related":[133],"cytokine":[134],"less":[136],"systemic":[137],"toxicity,":[138],"demonstrated":[141],"selective":[142],"our":[145],"highly":[146],"aggressive":[147],"androgen-independent":[148],"cell":[151],"line":[152],"(CL1).":[153],"Further":[154],"studies":[157],"are":[158],"being":[159],"conducted":[160],"evaluate":[162],"overall":[164],"efficacy":[165],"Apo2L/TRAIL":[169],"combination":[173],"antisense":[176],"treatment.":[180]},"counts_by_year":[],"updated_date":"2026-08-26T07:47:46.906454","created_date":"2016-06-24T00:00:00"}